(Q46184154)

English

Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

1 reference

based on heuristic

inferred from title

author name string

Robert J Connor

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

Jennifer M Anderson

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

Todd Machemer

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

Daniel C Maneval

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

Heidrun Engler

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

66

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

224-229

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

Potential of interferon-alpha in solid tumours: part 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

A randomized comparative dose-ranging study of interferon-alpha and mitomycin-C as an internal control in primary or recurrent superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Potential of interferon-alpha in solid tumours: part 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Gene-based vaccines and immunotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Molecular basis of the inflammatory response to adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.02.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.UROLOGY.2005.02.015

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/15992886

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46184154&oldid=2098982642"